PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27605551-5	2016	Cy/Flu minimized the effects of an immune response to the murine single-chain variable fragment component of the CAR, which limited CAR-T cell expansion and clinical efficacy in patients who received Cy-based lymphodepletion without Flu.	Cyclophosphamide	0-2	nuclear receptor subfamily 1, group I, member 3	Mus musculus	113-116	
33796409-6	2021	With the addition of one-day prior cyclophosphamide (CY) lymphodepletion, anti-CEA CAR T cell treatment delayed the median survival of MC38/CEA and E0771/CEA tumor-bearing CEATg mice by ten and 3 days, respectively.	Cyclophosphamide	35-51	nuclear receptor subfamily 1, group I, member 3	Mus musculus	83-86	
33796409-6	2021	With the addition of one-day prior cyclophosphamide (CY) lymphodepletion, anti-CEA CAR T cell treatment delayed the median survival of MC38/CEA and E0771/CEA tumor-bearing CEATg mice by ten and 3 days, respectively.	Cyclophosphamide	53-55	nuclear receptor subfamily 1, group I, member 3	Mus musculus	83-86	
27605551-5	2016	Cy/Flu minimized the effects of an immune response to the murine single-chain variable fragment component of the CAR, which limited CAR-T cell expansion and clinical efficacy in patients who received Cy-based lymphodepletion without Flu.	Cyclophosphamide	0-2	nuclear receptor subfamily 1, group I, member 3	Mus musculus	132-135	
27605551-5	2016	Cy/Flu minimized the effects of an immune response to the murine single-chain variable fragment component of the CAR, which limited CAR-T cell expansion and clinical efficacy in patients who received Cy-based lymphodepletion without Flu.	Cyclophosphamide	200-202	nuclear receptor subfamily 1, group I, member 3	Mus musculus	113-116	
27605551-5	2016	Cy/Flu minimized the effects of an immune response to the murine single-chain variable fragment component of the CAR, which limited CAR-T cell expansion and clinical efficacy in patients who received Cy-based lymphodepletion without Flu.	Cyclophosphamide	200-202	nuclear receptor subfamily 1, group I, member 3	Mus musculus	132-135